Navigation Links
Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
Date:3/2/2009

es even while taking up to three antiepileptic drugs (AED). The trial enrolled 147 patients at 24 sites in the U.S. Patients were observed for baseline seizure activity for 8 weeks and were then randomized to receive either ganaxolone or placebo in addition to their existing stable AED regimen. Patients entering the trial were experiencing, on average, 8 to 11 seizures per month. The most common background AEDs in the trial were lamotrigine, levetiracetam, carbamazepine, and topiramate.

Patients randomized to the ganaxolone treatment arm were titrated over one to two weeks to a maintenance dose of 1,500 mg/day where they were maintained for an additional 8 weeks. Patients in the ganaxolone arm met the primary endpoint showing a statistically significant reduction of mean weekly seizure frequency vs. the placebo arm during the titration and maintenance period (P<0.0251). In addition, the patients in the ganaxolone arm also showed an improvement on percent reduction in seizure frequency vs. placebo (P<0.0144). Responder rates (patients with greater than 50 percent reduction in seizures) were numerically larger in the ganaxolone arm vs. placebo but did not reach statistical significance in this study (P<0.1926).

"It is encouraging to see these positive results for a novel compound such as ganaxolone," states Joyce Cramer, president of the Epilepsy Therapy Project. "Thirty percent of epilepsy patients still do not have their epilepsy controlled with current antiepileptic drugs. There is a clear need for new treatment options, especially drugs with new mechanisms of action to complement the currently available therapies."

Ganaxolone was generally well tolerated with the majority of patients able to escalate and maintain the 1500 mg/day dose. The discontinuation rates due to adverse events between placebo and ganaxolone arms were 6 percent and 7 percent, respectively. The most commonly reported adve
'/>"/>

SOURCE Marinus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
2. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
3. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
4. Angiotech Pharmaceuticals, Inc. - Notice of conference call and webcast
5. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
6. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
7. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
8. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
9. Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor
10. Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
11. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015 Calling all runners, walkers ... and other tick-borne diseases! The first annual “Lyme Walk & ... Park in Stamford, CT. The event, hosted by Lyme ... will raise funds to support research and education about Lyme ... to all ages and abilities, will feature 5K and 10K ...
(Date:3/31/2015)... March 31, 2015 Many people, including ... basketball, rock climbing, and cycling are only for able-bodied ... at Memorial Rehabilitation Institute aims to change that thinking. ... System, will host an Adaptive Sports Expo on Saturday, ... Regional Hospital South in Hollywood. , The event ...
(Date:3/31/2015)... 31, 2015 Indosoft, developer of the Q-Suite ... support in development of their 5.x line. The industry ... been deployed around the world for more than a decade. ... a telephony platform, Q-Suite can fully embrace newer Asterisk features ... center software on Asterisk for more than a decade. The ...
(Date:3/31/2015)... KL Malaysia (PRWEB) March 31, 2015 ... need and requirement for education in a drastically different ... way in which learning and training content is being ... is being impacted by technology in an unprecedented way ... everyone, said Wemel Cumavoo, co-founder and CEO, My Mobile ...
(Date:3/31/2015)... The Walk a Mile Project, as part of their documentary ... their 3rd research sequence. The new sequence focuses on ... was and is a massive component of GMO regulation in ... World Films. “We started our research by going way ... food supply, just to get a bird's eye and big ...
Breaking Medicine News(10 mins):Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2
... Researchers at North Carolina State University have successfully modified ... specific cells inside the human body, without affecting surrounding ... of times smaller than the width of a human ... with greatly reduced, or even eliminated, side effects. , ...
... 12 Harris Corporation,(NYSE: HRS ... has been awarded a ten-year contract by ... to provide network,management and IT services for ... First Infrastructure Services (HFIS) contract includes,software and ...
... Feb. 12 When an emergency squad pulls up to ... New York, chances are the paramedics have received a new ... the University of Rochester Medical Center.The institution is ... (EMTs) and paramedics with video podcast lessons downloadable onto iPods ...
... in blindness and crumbling teeth have found a single ... tooth development. , A previously undiscovered and ... has been uncovered by researchers from the University of ... village in the war-torn Gaza strip. , Funded ...
... The Terri Lynne Lokoff Child Care Foundation (TLLCCF) ... TYLENOL(R) National Child Care Teacher Awards(TM). Fifty exemplary ... the United States and on U.S. Military bases in ... to maintaining high-quality child care practices and dedication to ...
... the body quickly needs to restore the vital blood volume. ... in the bone marrow. These hematopoietic stem cells remain dormant ... case of injury and loss of blood. Then they immediately ... cells. This has recently been shown by a group of ...
Cached Medicine News:Health News:Nanoparticle 'smart bomb' targets drug delivery to cancer cells 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 3Health News:University of Rochester Launches iTraining for Emergency Responders 2Health News:Gaza strip families give first clue to condition causing blindness and tooth decay 2Health News:Terri Lynne Lokoff Child Care Foundation Announces Recipients of the 2009 Terri Lynne Lokoff/Children's TYLENOL(R) National Child Care Teacher Awards(TM) 2Health News:Stem cells: Deathly awakening by interferon 2
(Date:3/31/2015)... PARK, N.C. , March 31, 2015  Dr. ... will be attending the World Orphan Drug Congress in April ... regulatory approval process and orphan drugs below: ... (DTAB) has recommended to the Ministry of Health that if ... country, marketing authorization can be obtained in India ...
(Date:3/31/2015)... 2015  Ariana Smith, a 17-year-old Taylor teen, became the ... , a part of the Detroit Medical Center (DMC), ... benefit from a revolutionary 3D printed heart model to aid ... In November, 2014, Ariana,s mom Jacqueline ... electrocardiogram (EKG), a test that checks for problems with the ...
(Date:3/31/2015)...  On May 2, 2015 global experts on ... Santa Monica, CA at the 5th ... Pleural Mesothelioma (MPM), a rare form of cancer ... affects the lining of the chest– the pleura. ... Pacific Mesothelioma Center (PMC). ...
Breaking Medicine Technology:Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 2Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 3Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 4Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 5Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4
... RALEIGH, N.C., Aug. 22, 2011 BioDelivery Sciences International, ... the commercial launch and availability of ONSOLIS (fentanyl buccal ...   (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO) ONSOLIS is ... it will be marketed as BREAKYL) for the management ...
... SPRING, Md., Aug. 19, 2011 The U.S. Food ... treat Hodgkin lymphoma (HL) and a rare lymphoma known ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Lymphomas are cancers of ... combines an antibody and drug, allowing the antibody to ...
Cached Medicine Technology:BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada 2BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada 3FDA Approves Adcetris to Treat Two Types of Lymphoma 2FDA Approves Adcetris to Treat Two Types of Lymphoma 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: